MBMehmet Bağlan

Mehmet Bağlan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mehmet Bağlan has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Synthesis, DFT Characterization and In Silico Evaluation of 1-(4-Methylpiperazin-1-yl-methyl)-3-benzyl-4-(4-hydroxybenzylideneamino)-4,5-dihydro-1H-1,2,4-triazol-5-one (MBHT)

    by Songül Boy, Kenan Gören, Mehmet Bağlan, Sevda Manap, Haydar Yüksek

    In this study, the compound 1-(4-methylpiperazin-1-yl-methyl)-3-benzyl-4-(4-hydroxybenzylideneamino)-4,5-dihydro-1H-1,2,4-triazol-5-one (MBHT), synthesized using the Mannich reaction, was comprehensively investigated using theoretical methods. The stable geometry of the molecule was optimized using the B3LYP and B3PW91 functionals within the framework of density functional theory (DFT) and with the basis set 6-311G(d,p). Structural characterization was performed by determining the functional groups using FT-IR spectroscopy and by detailed investigation of the proton and carbon environments using 1H-NMR and 13C-NMR spectroscopies. Theoretical IR and NMR data were calculated using Gaussian 09W software and the GIAO method; the obtained results were validated by comparing them with experimental findings. The molecule's electronic structure was evaluated in detail through parameters such as HOMO–LUMO energy levels and energy gap, Natural Bond Orbital (NBO) analysis, nonlinear optical (NLO) properties, molecular electrostatic potential (MEP) maps, and Mulliken charge distributions. These analyses provided information about MBHT's electron distribution, reactivity profile, and potential interaction sites. Furthermore, molecular docking studies were performed using PDB:5HS1 and PDB:5EQB proteins to investigate its in-silico potential for biological interaction with candidiasis. In the final part of the study, ADMET (absorption, distribution, metabolism, excretion, and toxicity) analysis was conducted to evaluate MBHT as a drug candidate. The findings reveal both the structural and electronic properties of MBHT, as well as its potential for interaction with biological targets, providing important information regarding the compound's suitability for the drug development process.

  • Design, Synthesis, Characterization, DFT Calculations, and Biological Evaluation with ADMET and Molecular Docking Studies of a Novel Schiff Base

    by Gül Kotan, Kenan Gören, Muzaffer Alkan, Abdurrahman Gürbüz, Mehmet Bağlan, Sevda Manap, Haydar Yüksek

  • Spectroscopic Characterization, DFT Analysis, Molecular Docking and ADMET Evaluation 1-(4-Methylpiperazin-1-ylmethyl)-3-p-chlorobenzyl-4-(4-hydroxybenzylideneamino)-4,5-dihydro-1H-1,2,4-triazol-5-one

    by Songül Boy, Kenan Gören, Mehmet Bağlan, Sevda Manap, Haydar Yüksek

    In this study, 1-(4-metilpiperazin-1-il-metil)-3-p-klorobenzil-4-(4-hidroksibenzilidenamino)-4,5-dihidro-1H-1,2,4-triazol-5-on (PCHT), a Mannich base derived from 1,2,4-triazole, was synthesized and its structural properties were investigated using both experimental and theoretical methods. The structure of the compound was experimentally characterized by FT-IR, ¹H-NMR, and ¹³C-NMR spectroscopic techniques. Geometric optimization of the molecule was performed using Density Functional Theory (DFT) with B3LYP and B3PW91 functionals and the 6-31G(d,p) basis set. Theoretical vibrational frequencies and FT-IR, ¹H-NMR and ¹³C-NMR NMR isotropic chemical shift values were calculated via the GIAO method and compared with the experimental data. Furthermore, electronic parameters such as Mulliken atomic charges, HOMO–LUMO energy levels, energy gap (ΔEg), dipole moment, ionization potential, electron affinity, chemical hardness, chemical softness, and electronegativity were calculated. Molecular electrostatic potential (MEP) surface maps were generated to identify the reactive sites of the molecule, and nucleophilic and electrophilic regions were analyzed. In addition, Natural Bond Orbital (NBO) analysis was conducted to examine the electronic structure in more detail, evaluating donor–acceptor interactions and hyperconjugation effects. To investigate the biological activity potential, molecular docking studies were performed, and the binding energies and molecular interactions between the ligand and the target protein were examined. Lastly, the compound's pharmacokinetic properties were assessed using ADMET analysis, which highlighted the molecule's possible drug-like qualities by looking at factors like Lipinski's "rule of five," bioavailability, water solubility, gastrointestinal absorption, and blood-brain barrier permeability.

  • Open Access

    Theoretical Investigation of the N-(4-(4-chlorophenyl)oxazol-2-yl)-4-phenyl-1H-pyrazole-3-carboxamide Molecule by DFT Method and Molecular Docking Evaluation Against SARS-CoV-2 Main Proteases

    by Barış Kartal, Kenan Gören, Mehmet Bağlan, Ümit Yıldıko

    In this study, N-(4-(4-chlorophenyl)oxazol-2-yl)-4-phenyl-1H-pyrazole-3-carboxamide (NOPC), a benzoxazole derivative with potential biological activity, was investigated in detail by theoretical and computational methods. The structural and electronic properties of the molecule were analyzed using the 6-31G(d,p) basis set with B3LYP and PBEPBE methods within the scope of Density Functional Theory (DFT). In this context, optimized geometry, HOMO-LUMO energy levels, NBO analysis, Mulliken charge distribution, NLO properties and MEPS surface were evaluated. In addition, the interaction of the NOPC molecule with 6W75 and 7BV2, the main proteases of the SARS-CoV-2 virus, was investigated by molecular docking method, and binding energies of -7.70 and -8.40 kcal/mol were obtained, respectively. These findings indicate that the molecule exhibits strong binding affinity and may be a potential inhibitor against COVID-19. Finally, ADME analyses performed with ADMETlab 2.0 revealed that NOPC complies with Lipinski rules and has high oral bioavailability potential. The obtained data indicate that NOPC molecule is a promising candidate for drug design.

  • DFT, Molecular Docking and In-Silico ADME Studies of 2-(2-(4-Chlorophenyl)Benzo[D]-Oxazol-5-Yl)Propanoic Acid Compound

    by Barış Kartal, Mehmet Bağlan, Kenan Gören

    As crucial building blocks of several chemical compounds, benzoxazole derivatives are currently garnering increased interest from chemists and biochemists for the creation of novel medications and pharmaceutical research. In this research, density functional theory (DFT) and B3PW91/B3LYP methods with 6-31G(d,p) basis set were used to optimize the molecular electrostatic potential (MEP), molecular orbital (HOMO-LUMO gap, hardness and softness), Nonlinear optical (NLO) and Mulliken charges properties of 2-(2-(4-chlorophenyl)benzo[d]oxazol-5-yl)propanoic acid (BOXP), a benzoxazole derivative. Additionally, the molecule conforms with Lipinski's rule and has promise in terms of bioavailability, according to pharmacokinetic parameters analyzed by ADME (absorption, distribution, metabolism, excretion) analysis utilizing Schrödinger Admetlab 2.0 software. Finally, molecular docking analysis was performed for 2HQ6 (colon cancer) and 4JPS (lung cancer), which are known target enzymes in cancer therapy. In the docking analysis, a score of -9.30 kcal/mol was obtained for the 2HQ6 enzyme code, while a score of -8.60 kcal/mol was obtained for the 4JPS enzyme code. These findings indicate that BOXP is a valuable molecule candidate for pharmaceutical development.

  • The Relationship Between AChE and BChE Enzymes and Alzheimer’s Disease: ADME, Molecular Docking, and DFT Studies of Schiff Base-Substituted Phenylpyrimidine

    by Kenan Gören, Mehmet Bağlan, Veysel Tahiroğlu, Ümit Yıldıko

    The theoretical molecular structure of Ethyl 2-(2-benzylidenehydrazinyl)-4-methyl-6-phenylpyrimidine-5-carboxylate (DHPM), a pyrimidine derivative containing the Schiff base structure, was investigated using the Gaussian 09 software program. The chemical structure and chemical reactivity of the compound were calculated using Density Functional Theory (DFT). Quantum chemical calculations were performed using DFT(B3LYP/6-311G(d,p)) and DFT(B3PW91/LANL2DZ) methods and basis sets. Using these two methods and basis sets, molecular electrostatic potential (MEP) maps of the DHPM compound were drawn. Charge transfer properties of DHPM compound were analyzed using HOMO and LUMO level energy analysis. The stability of molecules as a consequence of charge delocalization and hyperconjugative interaction was studied using NBO analysis. In this study, the relationship between Alzheimer's disease and Acetylcholinesterase (AChE) (PDB:6WUY) and Butyrylcholinesterase (BChE) (PDB: 6SAM) enzymes was evaluated by molecular docking. The molecular docking scores of in molecular docking analysis were found to be -7.76 (PDB ID: 6WUY) and -7.98 (PDB ID: 6SAM) kcal. Finally in the study, ADME analysis was performed to evaluate DHPM compound as a drug according to Lipinski's rules. As a result of the ADME analysis, we think that DHPM compound will be evaluated as a drug candidate since it complies with Lipinski's rules.


  • In-silico Drug Evaluation by Molecular Docking and ADME Studies, DFT Calculations of 2-(4-Chlorobenzyl)-6-(4-methoxyphenyl)imidazo [2,1-b][1,3,4]thiadiazole

    by Kenan Gören, Mehmet Bağlan, Veysel Tahiroğlu, Ümit Yıldıko

    The discovery of the imidazo[2,1-b][1,3,4]thiadiazole heterocycle was seen in the 1950s. The pharmacological potential of imidazo[2,1-b][1,3,4]thiadiazole derivatives as antibacterial, antifungal, anticonvulsant, anticancer, analgesic, anti-inflammatory, diuretic, and anesthetic has been extensively studied. The present investigation is to examine the 2-(4-Chlorobenzyl)-6-(4-methoxyphenyl)imidazo[2,1-b][1,3,4]thiadiazole (CMT) compound theoretically with the Gaussian 09 software program. The mentioned compound’s theoretical calculations were done on using the popular density functional theory (DFT) theories B3LYP, MPW1PW91 methods, the 6-311G(d,p) basis set. The highest occupied molecular orbital (HOMO), lowest unoccupied molecular orbital LUMO, natural bonding orbital NBO, nonlinear optical (NLO), molecular electrostatic potential (MEP), and Mulliken charges of the optimized structure were calculated theoretically with the same basis set and different methods, and the obtained values were compared with each other. Additionally, in silico studies were conducted to estimate the absorption, distribution, metabolism, excretion and toxicity (ADME) profiles of CMT compound to evaluate it as a drug. Based on the ADME study, we believe that the compound will have good potential drug-like character. Finally, 3PP0 and 1M17 enzymes were downloaded from PDB (Protein Data Bank) and the potential of CMT compound on breast cancer was calculated in silico by molecular docking analysis. According to the docking analysis outcomes, the docking score of CMT compound was obtained as -10.20 and -7.50 kcal/mol, respectively. In the docking analysis, it was shown that the theoretical data on breast cancer were well correlated with the observed values.


  • Open Access

    In Silico drug evaluation by molecular docking, ADME studies and DFT calculations of 2-(6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl)-N, N-dipropylacetamide

    by Veysel Tahiroğlu, Kenan Gören, Mehmet Bağlan

    In this study, the structural, electronic, pharmacokinetic, and biological properties of molecule 2-(6-kloro-2-(4-klorofenil)imidazo[1,2-a]piridin-3-il)-N, N-dipropilasetamid (Alpidem), an imidazopyridine derivative anxiolytic known for its high BZ₁ (benzodiazepine-1) receptor affinity and low adverse effect profile, were comprehensively investigated by density functional theory (DFT) and in-silico methods. The alpidem molecule was optimized using the 6-311G(d, p) basis set with the B3LYP and B3PW91 methods; information on the stability and chemical reactivity of the structure was obtained via the highest occupied molecular orbital (HOMO), lowest unoccupied molecular orbital (LUMO), molecular electrostatic potential (MEP) maps, natural bonding orbital (NBO) analysis, non-linear optical (NLO) properties, and Mulliken charge distributions. Comparative analysis of two different methods has shown that the results are consistent with each other and provide reliable data. In addition, the drug similarity, bioavailability score, bioactivity values, absorption, distribution, metabolism, and excretion (ADME) profiles of the Alpidem molecule were calculated, and it was determined that the Alpidem molecule has pharmacologically favorable properties. Within the scope of molecular docking analyses, its interactions with two different enzymes (PDB ID: 2Z5X and 4BDT) associated with Alzheimer’s disease were evaluated. The binding energy values obtained were − 8.00 kcal/mol (2Z5X) and − 9.60 kcal/mol (4BDT), respectively, and the strong binding affinity, especially with the 4BDT protein, suggests that Alpidem may be a potential inhibitor candidate in Alzheimer’s disease. This multi-level theoretical study demonstrates that Alpidem is a drug repurposing molecule not only as an anxiolytic but also in neurodegenerative diseases and provides important data that will shed light on experimental studies. The results of this multi-level theoretical study show that Alpidem is a drug repurposing molecule not only as an anxiolytic but also in neurodegenerative diseases and provides important data that will shed light on experimental studies.